Fatty acid metabolism in the Plasmodium apicoplast: Drugs, doubts and knockouts.
暂无分享,去创建一个
G. McFadden | Melanie J. Shears | Cyrille Y. Botté | Geoffrey I McFadden | Melanie J Shears | Cyrille Y Botté
[1] S. Kappe,et al. 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. , 2010, Bioorganic & medicinal chemistry.
[2] C. Janse,et al. Stable transfection of malaria parasite blood stages. , 1995, Science.
[3] G. Folkers,et al. Recombinant Expression and Biochemical Characterization of the Unique Elongating β-Ketoacyl-Acyl Carrier Protein Synthase Involved in Fatty Acid Biosynthesis of Plasmodium falciparum Using Natural and Artificial Substrates* , 2006, Journal of Biological Chemistry.
[4] K. Athenstaedt,et al. Phosphatidic acid, a key intermediate in lipid metabolism. , 1999, European journal of biochemistry.
[5] A. Kuehn,et al. The Coming-Out of Malaria Gametocytes , 2010, Journal of biomedicine & biotechnology.
[6] S. Hoffman,et al. Type II Fatty Acid Biosynthesis Is Essential for Plasmodium falciparum Sporozoite Development in the Midgut of Anopheles Mosquitoes , 2013, Eukaryotic Cell.
[7] R. Lyons,et al. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. , 2001, International journal for parasitology.
[8] J. Schachtner,et al. Apicomplexan parasites contain a single lipoic acid synthase located in the plastid , 2003, FEBS letters.
[9] H. Asahi,et al. Investigating serum factors promoting erythrocytic growth of Plasmodium falciparum. , 2005, Experimental parasitology.
[10] C. Biot,et al. The apicoplast: a key target to cure malaria. , 2012, Current pharmaceutical design.
[11] Rahul Modak,et al. Isothermal unfolding studies on the apo and holo forms of Plasmodium falciparum acyl carrier protein , 2007, The FEBS journal.
[12] V. Heussler,et al. Mitochondrial lipoic acid scavenging is essential for Plasmodium berghei liver stage development , 2012, Cellular microbiology.
[13] N. Waters,et al. Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[14] I. Sherman,et al. Phospholipid composition, cholesterol content and cholesterol exchange in Plasmodium falciparum-infected red cells. , 1990, Molecular and biochemical parasitology.
[15] Terry K. Smith,et al. Apicoplast Lipoic Acid Protein Ligase B Is Not Essential for Plasmodium falciparum , 2007, PLoS pathogens.
[16] C. Benning. Mechanisms of lipid transport involved in organelle biogenesis in plant cells. , 2009, Annual review of cell and developmental biology.
[17] H. Asahi. Plasmodium falciparum: Chemically defined medium for continuous intraerythrocytic growth using lipids and recombinant albumin. , 2009, Experimental parasitology.
[18] M. Mather,et al. Mitochondrial drug targets in apicomplexan parasites. , 2007, Current drug targets.
[19] Manuel Llinás,et al. Kinetic Flux Profiling Elucidates Two Independent Acetyl-CoA Biosynthetic Pathways in Plasmodium falciparum* , 2013, The Journal of Biological Chemistry.
[20] Joel S. Freundlich,et al. The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. , 2008, Cell host & microbe.
[21] S. Sharma,et al. Solution structures of conformationally equilibrium forms of holo-acyl carrier protein (PfACP) from Plasmodium falciparum provides insight into the mechanism of activation of ACPs. , 2006, Biochemistry.
[22] Takuya Maeda,et al. Pyruvate kinase type-II isozyme in Plasmodium falciparum localizes to the apicoplast. , 2009, Parasitology international.
[23] G. McFadden,et al. Fatty acid biosynthesis as a drug target in apicomplexan parasites. , 2007, Current drug targets.
[24] Rahul Modak,et al. Mass Spectrometry-Based Systems Approach for Identification of Inhibitors of Plasmodium falciparum Fatty Acid Synthase , 2007, Antimicrobial Agents and Chemotherapy.
[25] D. Rice,et al. Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii , 2013, ChemMedChem.
[26] Deniz Tasdemir,et al. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. , 2006, Journal of medicinal chemistry.
[27] Karsten Fischer,et al. The toxoplasma apicoplast phosphate translocator links cytosolic and apicoplast metabolism and is essential for parasite survival. , 2010, Cell host & microbe.
[28] T. Sim,et al. Plasmodium falciparum pyruvate kinase as a novel target for antimalarial drug-screening. , 2007, Travel medicine and infectious disease.
[29] C. Janse,et al. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei , 2006, Nature Protocols.
[30] G. McFadden,et al. Targeting apicoplasts in malaria parasites , 2013, Expert opinion on therapeutic targets.
[31] Aditi Gupta,et al. Functional characterization of beta-ketoacyl-ACP reductase (FabG) from Plasmodium falciparum. , 2003, Biochemical and biophysical research communications.
[32] P. T. Englund,et al. A fatty-acid synthesis mechanism specialized for parasitism , 2007, Nature Reviews Microbiology.
[33] Eileen Kraemer,et al. PlasmoDB: a functional genomic database for malaria parasites , 2008, Nucleic Acids Res..
[34] C. Spry,et al. A Class of Pantothenic Acid Analogs Inhibits Plasmodium falciparum Pantothenate Kinase and Represses the Proliferation of Malaria Parasites , 2005, Antimicrobial Agents and Chemotherapy.
[35] B. Striepen,et al. Make It or Take It: Fatty Acid Metabolism of Apicomplexan Parasites , 2007, Eukaryotic Cell.
[36] Christopher J. Tonkin,et al. Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast , 2004, Nature Reviews Microbiology.
[37] N. Surolia,et al. Analyses of co‐operative transitions in Plasmodium falciparumβ‐ketoacyl acyl carrier protein reductase upon co‐factor and acyl carrier protein binding , 2006, The FEBS journal.
[38] Avadhesha Surolia,et al. β‐Ketoacyl‐ACP synthase I/II from Plasmodium falciparum (PfFabB/F)—Is it B or F? , 2009, IUBMB life.
[39] D. Fidock,et al. Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein Reductase* , 2002, The Journal of Biological Chemistry.
[40] G. Klebe,et al. Novel Type II Fatty Acid Biosynthesis (FAS II) Inhibitors as Multistage Antimalarial Agents , 2013, ChemMedChem.
[41] S. Prigge,et al. Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. , 2009, Journal of medicinal chemistry.
[42] D. Roos,et al. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Cowman,et al. Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Parsons,et al. Apicoplast Targeting of a Toxoplasma gondii Transmembrane Protein Requires a Cytosolic Tyrosine‐Based Motif , 2012, Traffic.
[45] Colin Berry,et al. Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents. , 2004, Bioorganic & medicinal chemistry.
[46] Joel S. Freundlich,et al. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay. , 2013, Biochemistry.
[47] N. Surolia,et al. Catalysis and mechanism of malonyl transferase activity in type II fatty acid biosynthesis acyl carrier proteins. , 2009, Molecular bioSystems.
[48] Kami Kim,et al. Toxoplasma gondii: the model apicomplexan. , 2004, International journal for parasitology.
[49] P. Gornicki. Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites. , 2003, International journal for parasitology.
[50] D. Rice,et al. Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase. , 2010, Journal of medicinal chemistry.
[51] G. McFadden,et al. The evolution, metabolism and functions of the apicoplast , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.
[52] Nicholas Fisher,et al. Glycerol: An unexpected major metabolite of energy metabolism by the human malaria parasite , 2009, Malaria Journal.
[53] R. Datla,et al. Molecular and biochemical characterizations of a plastidic glycerol-3-phosphate dehydrogenase from Arabidopsis , 2001 .
[54] M. Gardner,et al. Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum. , 2002, Molecular and biochemical parasitology.
[55] P. Tonge,et al. Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[56] Y. Wu. Transfection of Plasmodiium falciparum within human red biood cells , 1995 .
[57] I. Coppens,et al. Cell cycle‐regulated vesicular trafficking of Toxoplasma APT1, a protein localized to multiple apicoplast membranes , 2007, Molecular microbiology.
[58] Joseph L. DeRisi,et al. Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum , 2011, PLoS biology.
[59] B. Striepen,et al. Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii , 2006, Proceedings of the National Academy of Sciences.
[60] R. Moritz,et al. Enzymes involved in plastid‐targeted phosphatidic acid synthesis are essential for Plasmodium yoelii liver‐stage development , 2014, Molecular microbiology.
[61] C. Spry,et al. Coenzyme A biosynthesis: an antimicrobial drug target. , 2008, FEMS microbiology reviews.
[62] S. Müller,et al. Lipoic Acid Metabolism of Plasmodium - A Suitable Drug Target , 2012, Current pharmaceutical design.
[63] N. Surolia,et al. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies. , 2005, Protein expression and purification.
[64] A. Kastaniotis,et al. Apicoplast and Endoplasmic Reticulum Cooperate in Fatty Acid Biosynthesis in Apicomplexan Parasite Toxoplasma gondii* , 2011, The Journal of Biological Chemistry.
[65] S. Müller,et al. Plasmodium falciparum: organelle-specific acquisition of lipoic acid. , 2009, The international journal of biochemistry & cell biology.
[66] A. Vaughan,et al. Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection , 2010, Molecular microbiology.
[67] R. Ménard,et al. Recent insights into fatty acid acquisition and metabolism in malarial parasites , 2010, F1000 biology reports.
[68] Christopher J. Tonkin,et al. Evidence for Golgi‐independent transport from the early secretory pathway to the plastid in malaria parasites , 2006, Molecular microbiology.
[69] R. Cibulskis,et al. World Malaria Report 2013 , 2014 .
[70] D. Soldati-Favre,et al. Functional genetics in Apicomplexa: Potentials and limits , 2011, FEBS letters.
[71] S. Levy,et al. Triclosan targets lipid synthesis , 1998, Nature.
[72] S. Prigge,et al. Lipoic Acid Metabolism in Microbial Pathogens , 2010, Microbiology and Molecular Biology Reviews.
[73] D. Rice,et al. Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase. , 2013, Bioorganic & medicinal chemistry letters.
[74] A. Fairlamb,et al. Triclosan is minimally effective in rodent malaria models , 2011, Nature Medicine.
[75] T. Ramya,et al. Inhibitors of Nonhousekeeping Functions of the Apicoplast Defy Delayed Death in Plasmodium falciparum , 2006, Antimicrobial Agents and Chemotherapy.
[76] S. Prigge,et al. Plasmodium falciparum acyl carrier protein crystal structures in disulfide‐linked and reduced states and their prevalence during blood stage growth , 2010, Proteins.
[77] S. Prigge,et al. Scavenging of the cofactor lipoate is essential for the survival of the malaria parasite Plasmodium falciparum , 2007, Molecular microbiology.
[78] A. Vaughan,et al. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development , 2008, Cellular microbiology.
[79] I. Gilbert,et al. Thiolactomycin analogues as potential anti-Toxoplasma gondii agents. , 2009, Parasitology international.
[80] A. Cavalli,et al. Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI). , 2013, Journal of medicinal chemistry.
[81] X. Su,et al. Transfection of Plasmodium falciparum within human red blood cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[82] T. Mitamura,et al. Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth , 2006, Parasitology.
[83] M. Gatton,et al. Fatty Acid Synthesis and Pyruvate Metabolism Pathways Remain Active in Dihydroartemisinin-Induced Dormant Ring Stages of Plasmodium falciparum , 2014, Antimicrobial Agents and Chemotherapy.
[84] Uwe Gross,et al. Carbohydrate Metabolism in the Toxoplasma gondii Apicoplast: Localization of Three Glycolytic Isoenzymes, the Single Pyruvate Dehydrogenase Complex, and a Plastid Phosphate Translocator , 2007, Eukaryotic Cell.
[85] J. Meuwissen,et al. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes , 1989, Parasitology.
[86] G. McFadden,et al. Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway , 2000, The EMBO journal.
[87] R. Ménard,et al. Looking under the skin: the first steps in malarial infection and immunity , 2013, Nature Reviews Microbiology.
[88] P. Frey,et al. S-adenosylmethionine as an oxidant: the radical SAM superfamily. , 2007, Trends in biochemical sciences.
[89] H. Vial,et al. Oleic Acid Biosynthesis in Plasmodium falciparum: Characterization of the Stearoyl-CoA Desaturase and Investigation as a Potential Therapeutic Target , 2009, PloS one.
[90] L. Sibley,et al. Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. , 2002, Journal of cell science.
[91] H. Majumder,et al. Luteolin, an Abundant Dietary Component is a Potent Anti-leishmanial Agent that Acts by Inducing Topoisomerase II-mediated Kinetoplast DNA Cleavage Leading to Apoptosis , 2000, Molecular medicine.
[92] R. Perozzo,et al. Anthecularin: a novel sesquiterpene lactone from Anthemis auriculata with antiprotozoal activity. , 2007, Journal of Organic Chemistry.
[93] N. Surolia,et al. Structural basis for the functional and inhibitory mechanisms of β-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Plasmodium falciparum. , 2011, Journal of structural biology.
[94] R. Sinden,et al. Laboratory models for research in vivo and in vitro on malaria parasites of mammals: Current status. , 1990, Parasitology today.
[95] F. Winkler,et al. The crystal structure of PfFabZ, the unique β‐hydroxyacyl‐ACP dehydratase involved in fatty acid biosynthesis of Plasmodium falciparum , 2005, Protein science : a publication of the Protein Society.
[96] G. Zhu,et al. Functional Characterization of an Evolutionarily Distinct Phosphopantetheinyl Transferase in the Apicomplexan Cryptosporidium parvum , 2005, Eukaryotic Cell.
[97] R. Haselkorn,et al. Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[98] Choukri Ben Mamoun,et al. Targeting the lipid metabolic pathways for the treatment of malaria , 2009, Drug development research.
[99] S. Prigge,et al. Redox‐dependent lipoylation of mitochondrial proteins in Plasmodium falciparum , 2014, Molecular microbiology.
[100] B. Humbel,et al. Membrane Contact Sites between Apicoplast and ER in Toxoplasma gondii Revealed by Electron Tomography , 2009, Traffic.
[101] D. Rice,et al. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents , 2007, Acta crystallographica. Section D, Biological crystallography.
[102] S. Kappe,et al. Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.
[103] Pamela G. Guren,et al. Candidates , 1982, Otolaryngology–Head and Neck Surgery.
[104] D. Mazier,et al. Complete development of hepatic stages of Plasmodium falciparum in vitro. , 1985, Science.
[105] S. Makino,et al. Molecular and biochemical characterization of Toxoplasma gondii β-hydroxyacyl-acyl carrier protein dehydratase (FABZ) , 2008, Parasitology Research.
[106] Joel S. Freundlich,et al. X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy* , 2007, Journal of Biological Chemistry.
[107] D. Soldati-Favre,et al. Apicomplexan mitochondrial metabolism: a story of gains, losses and retentions. , 2008, Trends in parasitology.
[108] R. Haselkorn,et al. The Carboxyltransferase Activity of the Apicoplast Acetyl-CoA Carboxylase of Toxoplasma gondii Is the Target of Aryloxyphenoxypropionate Inhibitors* , 2002, The Journal of Biological Chemistry.
[109] Jérôme Garin,et al. Chloroplast proteomics highlights the subcellular compartmentation of lipid metabolism. , 2010, Progress in lipid research.
[110] G. McFadden,et al. Plasmodium falciparum apicoplast drugs: targets or off-targets? , 2012, Chemical reviews.
[111] N. Surolia,et al. Triclosan inhibit the growth of the late liver‐stage of Plasmodium , 2009, IUBMB life.
[112] S. Ralph,et al. A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum , 2003, Antimicrobial Agents and Chemotherapy.
[113] S. Sharma,et al. Crystal structure of dimeric FabZ of Plasmodium falciparum reveals conformational switching to active hexamers by peptide flips , 2006, FEBS letters.
[114] V. Nussenzweig,et al. Gene targeting in the rodent malaria parasite Plasmodium yoelii. , 2001, Molecular and biochemical parasitology.
[115] E. Winzeler,et al. A key role for lipoic acid synthesis during Plasmodium liver stage development , 2013, Cellular microbiology.
[116] G. McFadden,et al. Dimeric cyclohexane-1,3-dione oximes inhibit wheat acetyl-CoA carboxylase and show anti-malarial activity. , 2010, Bioorganic & medicinal chemistry letters.
[117] A. Alcina,et al. The cloning and expression of Pfacs1, a Plasmodium falciparum fatty acyl coenzyme A synthetase-1 targeted to the host erythrocyte cytoplasm. , 1999, Journal of molecular biology.
[118] N. Surolia,et al. X‐ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition , 2010, IUBMB life.
[119] J. Keithly,et al. Expression and functional characterization of a giant Type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum. , 2004, Molecular and biochemical parasitology.
[120] S. Müller,et al. Vitamin and cofactor biosynthesis pathways in Plasmodium and other apicomplexan parasites. , 2007, Trends in parasitology.
[121] Xinxia Peng,et al. A combined transcriptome and proteome survey of malaria parasite liver stages , 2008, Proceedings of the National Academy of Sciences.
[122] G. McFadden,et al. The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast , 2004, Molecular microbiology.
[123] Joel S. Freundlich,et al. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives. , 2006, Bioorganic & medicinal chemistry letters.
[124] T. Ramya,et al. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. , 2006, Bioorganic & medicinal chemistry.
[125] E. Maréchal,et al. Toxoplasma gondii acyl-lipid metabolism: de novo synthesis from apicoplast-generated fatty acids versus scavenging of host cell precursors. , 2006, The Biochemical journal.
[126] Rahul Modak,et al. Deciphering the key residues in Plasmodium falciparumβ‐ketoacyl acyl carrier protein reductase responsible for interactions with Plasmodium falciparum acyl carrier protein , 2008, The FEBS journal.
[127] A. Aly,et al. Plasmodium yoelii Vitamin B5 Pantothenate Transporter Candidate is Essential for Parasite Transmission to the Mosquito , 2014, Scientific Reports.
[128] J. Vanderberg,et al. Complete in vitro maturation of Plasmodium falciparum gametocytes , 1981, Nature.
[129] S. Sharma,et al. Identification, Characterization, and Inhibition of Plasmodium falciparum β-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ)* , 2003, Journal of Biological Chemistry.
[130] Choukri Ben Mamoun,et al. Identification and Functional Analysis of the Primary Pantothenate Transporter, PfPAT, of the Human Malaria Parasite Plasmodium falciparum* , 2013, The Journal of Biological Chemistry.
[131] S. Hoffman,et al. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. , 2012, Vaccine.
[132] C. Rock,et al. Forty years of bacterial fatty acid synthesis. , 2002, Biochemical and biophysical research communications.
[133] A. Alcina,et al. The Plasmodium falciparum fatty acyl-CoA synthetase family (PfACS) and differential stage-specific expression in infected erythrocytes. , 2003, Molecular and biochemical parasitology.
[134] T. Mitamura,et al. Serum factors governing intraerythrocytic development and cell cycle progression of Plasmodium falciparum. , 2000, Parasitology international.
[135] K. Saliba,et al. Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite , 2008, BMC Research Notes.
[136] S. Prigge,et al. Lactococcus lactis fabH, Encoding β-Ketoacyl-Acyl Carrier Protein Synthase, Can Be Functionally Replaced by the Plasmodium falciparum Congener , 2010, Applied and Environmental Microbiology.
[137] G. McFadden,et al. The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites. , 2003, International review of cytology.
[138] D. Rice,et al. Delivery of antimicrobials into parasites , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[139] G. V. van Dooren,et al. The algal past and parasite present of the apicoplast. , 2013, Annual review of microbiology.
[140] A. Vaughan,et al. Malaria parasite development in the mosquito and infection of the mammalian host. , 2009, Annual review of microbiology.
[141] S. Ralph,et al. Membrane transporters in the relict plastid of malaria parasites. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[142] J. Cronan,et al. In Vivo Functional Analyses of the Type II Acyl Carrier Proteins of Fatty Acid Biosynthesis* , 2007, Journal of Biological Chemistry.
[143] A. Fairlamb,et al. Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis. , 2006, The Biochemical journal.
[144] G. McFadden,et al. Apicoplast acetyl Co-A carboxylase of the human malaria parasite is not targeted by cyclohexanedione herbicides. , 2014, International journal for parasitology.
[145] S. Prigge,et al. Malaria pulls a FASt one. , 2008, Cell host & microbe.
[146] S. Booker,et al. Identification and function of auxiliary iron-sulfur clusters in radical SAM enzymes. , 2012, Biochimica et biophysica acta.
[147] S. Sharma,et al. Self-acylation properties of type II fatty acid biosynthesis acyl carrier protein. , 2007, Chemistry & biology.
[148] S. Prigge,et al. Fatty Acid synthesis as a target for antimalarial drug discovery. , 2005, Combinatorial chemistry & high throughput screening.
[149] C. Spry,et al. The Human Malaria Parasite Plasmodium falciparum Is Not Dependent on Host Coenzyme A Biosynthesis* , 2009, The Journal of Biological Chemistry.
[150] Joachim Schachtner,et al. Toxoplasma gondii scavenges host‐derived lipoic acid despite its de novo synthesis in the apicoplast , 2006, The EMBO journal.
[151] D. Fidock,et al. In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin* , 2007, Journal of Biological Chemistry.
[152] C. Rock,et al. Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. , 1989, The Journal of biological chemistry.
[153] G. McFadden,et al. The carbon and energy sources of the non‐photosynthetic plastid in the malaria parasite , 2010, FEBS letters.
[154] C. C. Maquiaveli,et al. The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase. , 2012, Experimental parasitology.
[155] I. Gilbert,et al. Analogues of thiolactomycin as potential antimalarial agents. , 2005, Journal of medicinal chemistry.
[156] M. Kapoor,et al. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. , 2004, The Biochemical journal.
[157] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[158] D. Roos,et al. A plastid segregation defect in the protozoan parasite Toxoplasma gondii , 2001, The EMBO journal.
[159] A. Rendina,et al. Inhibition of acetyl-coenzyme A carboxylase by two classes of grass-selective herbicides , 1990 .
[160] A. Vaughan,et al. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. , 2011, Cell host & microbe.
[161] D. Soldati-Favre,et al. Apicoplast: keep it or leave it. , 2010, Microbes and infection.
[162] G. Kumar,et al. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl‐acyl carrier protein reductase , 2010, IUBMB life.
[163] M. Strath,et al. Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. , 1996, Journal of molecular biology.
[164] C. Rock,et al. Phosphatidic acid synthesis in bacteria. , 2013, Biochimica et biophysica acta.
[165] N. Surolia,et al. Apicoplast triose phosphate transporter (TPT) gene knockout is lethal for Plasmodium. , 2012, Molecular and biochemical parasitology.
[166] S. Prigge,et al. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII. , 2003, Biochemistry.
[167] A. Vaughan,et al. Redefining the role of de novo fatty acid synthesis in Plasmodium parasites. , 2009, Trends in parasitology.
[168] G. McFadden,et al. The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenases , 2004, Molecular microbiology.
[169] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[170] H. Vial,et al. Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways. , 2010, International journal for parasitology.
[171] K. Fritz-Wolf,et al. Biochemical and structural characterization of Plasmodium falciparum glutamate dehydrogenase 2. , 2012, Molecular and biochemical parasitology.
[172] M. Kapoor,et al. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. , 2001, Biochemical and biophysical research communications.
[173] S. Sharma,et al. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. , 2007, Journal of medicinal chemistry.
[174] D. Gowda,et al. Intraerythrocytic Plasmodium falciparum incorporates extraneous fatty acids to its lipids without any structural modification. , 2003, Molecular and biochemical parasitology.
[175] U. Murty,et al. Deorphanization of Malonyl CoA:ACP Transacylase Drug Target in Plasmodium falciparum (PfFabD) Using Bacterial Antagonists: A ‘Piggyback’ Approach for Antimalarial Drug Discovery , 2012, Molecular informatics.
[176] S. Müller,et al. Knockout Studies Reveal an Important Role of Plasmodium Lipoic Acid Protein Ligase A1 for Asexual Blood Stage Parasite Survival , 2009, PloS one.
[177] Elena R. Lozovsky,et al. Duplication, gene conversion, and genetic diversity in the species-specific acyl-CoA synthetase gene family of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.
[178] David S. Roos,et al. A plastid organelle as a drug target in apicomplexan parasites , 1997, Nature.
[179] S. Müller,et al. The human malaria parasite Plasmodium falciparum has distinct organelle‐specific lipoylation pathways , 2004, Molecular microbiology.
[180] R. Compans,et al. Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses , 2010, Journal of biomedicine & biotechnology.
[181] R. Coleman,et al. The Plasmodium falciparum PfGatp is an Endoplasmic Reticulum Membrane Protein Important for the Initial Step of Malarial Glycerolipid Synthesis* , 2004, Journal of Biological Chemistry.
[182] S. Booker. Unraveling the pathway of lipoic acid biosynthesis. , 2004, Chemistry & biology.
[183] R. Haselkorn,et al. Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[184] Dominique Soldati-Favre,et al. Dual Targeting of Antioxidant and Metabolic Enzymes to the Mitochondrion and the Apicoplast of Toxoplasma gondii , 2007, PLoS pathogens.
[185] Malcolm J. McConville,et al. BCKDH: The Missing Link in Apicomplexan Mitochondrial Metabolism Is Required for Full Virulence of Toxoplasma gondii and Plasmodium berghei , 2014, PLoS pathogens.
[186] S. Krungkrai,et al. Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential. , 2011, Asian Pacific journal of tropical biomedicine.
[187] V. Heussler,et al. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine. , 2013, International journal for parasitology.
[188] A. Regev,et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients , 2007, Nature.
[189] J. E. Hyde,et al. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. , 2010, Trends in parasitology.
[190] R. U. Byerrum,et al. Plant dihydroxyacetone phosphate reductases : purification, characterization, and localization. , 1992, Plant physiology.
[191] N. Surolia,et al. Structural Insights into the Acyl Intermediates of the Plasmodium falciparum Fatty Acid Synthesis Pathway , 2009, The Journal of Biological Chemistry.
[192] R. Haselkorn,et al. An isoleucine/leucine residue in the carboxyltransferase domain of acetyl-CoA carboxylase is critical for interaction with aryloxyphenoxypropionate and cyclohexanedione inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[193] K. Christensen,et al. Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1. , 2011, Experimental parasitology.
[194] G. Zhu,et al. Functional characterizations of malonyl-CoA:acyl carrier protein transacylase (MCAT) in Eimeria tenella. , 2012, Molecular and biochemical parasitology.
[195] G. McFadden,et al. Atypical lipid composition in the purified relict plastid (apicoplast) of malaria parasites , 2013, Proceedings of the National Academy of Sciences.
[196] A. Verma,et al. Comparative modeling of 3-oxoacyl-acyl-carrier protein synthase I/II in Plasmodium falciparum - A potent target of malaria , 2010 .
[197] B. Striepen,et al. Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans. , 2013, Progress in lipid research.
[198] G. McFadden. The apicoplast , 2010, Protoplasma.